Willis Towers Watson [WTW] vs Marsh & McLennan [MMC] Detailed Stock Comparison

Willis Towers Watson
NASDAQ
Loading...

Marsh & McLennan
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Willis Towers Watson wins in 9 metrics, Marsh & McLennan wins in 11 metrics, with 0 ties. Marsh & McLennan appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Willis Towers Watson | Marsh & McLennan | Better |
---|---|---|---|
P/E Ratio (TTM) | 227.31 | 25.32 | Marsh & McLennan |
Price-to-Book Ratio | 4.06 | 6.58 | Willis Towers Watson |
Debt-to-Equity Ratio | 72.56 | 135.27 | Willis Towers Watson |
PEG Ratio | 1.58 | 3.21 | Willis Towers Watson |
EV/EBITDA | 14.17 | 16.34 | Willis Towers Watson |
Profit Margin (TTM) | 1.40% | 16.00% | Marsh & McLennan |
Operating Margin (TTM) | 16.94% | 26.91% | Marsh & McLennan |
EBITDA Margin (TTM) | 16.94% | 26.91% | Marsh & McLennan |
Return on Equity | 1.67% | 28.41% | Marsh & McLennan |
Return on Assets (TTM) | 4.66% | 7.86% | Marsh & McLennan |
Free Cash Flow (TTM) | $1.27B | $3.99B | Marsh & McLennan |
Dividend Yield | 1.51% | 1.51% | Marsh & McLennan |
1-Year Return | 20.53% | -5.72% | Willis Towers Watson |
Price-to-Sales Ratio (TTM) | 3.35 | 4.02 | Willis Towers Watson |
Enterprise Value | $36.75B | $123.84B | Marsh & McLennan |
EV/Revenue Ratio | 3.75 | 4.80 | Willis Towers Watson |
Gross Profit Margin (TTM) | 35.91% | 44.15% | Marsh & McLennan |
Revenue per Share (TTM) | $98 | $52 | Willis Towers Watson |
Earnings per Share (Diluted) | $1.48 | $8.33 | Marsh & McLennan |
Beta (Stock Volatility) | 0.68 | 0.78 | Willis Towers Watson |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Willis Towers Watson vs Marsh & McLennan Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Willis Towers Watson | 0.62% | 2.64% | 9.91% | 10.12% | 3.36% | 9.69% |
Marsh & McLennan | -0.27% | 1.61% | 0.12% | -7.84% | -9.58% | -0.37% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Willis Towers Watson | 20.53% | 63.25% | 64.96% | 195.28% | 335.77% | 284.46% |
Marsh & McLennan | -5.72% | 26.87% | 84.69% | 288.97% | 778.76% | 680.68% |
Performance & Financial Health Analysis: Willis Towers Watson vs Marsh & McLennan
Metric | WTW | MMC |
---|---|---|
Market Information | ||
Market Cap | $32.82B | $103.70B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 602,709 | 2,292,330 |
90 Day Avg. Volume | 682,463 | 2,608,213 |
Last Close | $339.24 | $210.55 |
52 Week Range | $280.86 - $344.14 | $196.27 - $248.00 |
% from 52W High | -1.42% | -15.10% |
All-Time High | $344.14 (Mar 03, 2025) | $248.00 (Mar 31, 2025) |
% from All-Time High | -1.42% | -15.10% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.00% | 0.12% |
Quarterly Earnings Growth | 1.35% | 0.08% |
Financial Health | ||
Profit Margin (TTM) | 0.01% | 0.16% |
Operating Margin (TTM) | 0.17% | 0.27% |
Return on Equity (TTM) | 0.02% | 0.28% |
Debt to Equity (MRQ) | 72.56 | 135.27 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $82.78 | $32.07 |
Cash per Share (MRQ) | $20.41 | $3.41 |
Operating Cash Flow (TTM) | $1.41B | $4.92B |
Levered Free Cash Flow (TTM) | $1.34B | $4.34B |
Dividends | ||
Last 12-Month Dividend Yield | 1.51% | 1.51% |
Last 12-Month Dividend | $4.48 | $3.24 |
Valuation & Enterprise Metrics Analysis: Willis Towers Watson vs Marsh & McLennan
Metric | WTW | MMC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 227.31 | 25.32 |
Forward P/E | 18.60 | 22.37 |
PEG Ratio | 1.58 | 3.21 |
Price to Sales (TTM) | 3.35 | 4.02 |
Price to Book (MRQ) | 4.06 | 6.58 |
Market Capitalization | ||
Market Capitalization | $32.82B | $103.70B |
Enterprise Value | $36.75B | $123.84B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.75 | 4.80 |
Enterprise to EBITDA | 14.17 | 16.34 |
Risk & Other Metrics | ||
Beta | 0.68 | 0.78 |
Book Value per Share (MRQ) | $82.78 | $32.07 |
Financial Statements Comparison: Willis Towers Watson vs Marsh & McLennan
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | WTW | MMC |
---|---|---|
Revenue/Sales | $2.22B | $7.06B |
Cost of Goods Sold | $1.32B | $3.85B |
Gross Profit | $899.00M | $3.21B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $432.00M | $2.01B |
EBITDA | $460.00M | $2.29B |
Pre-Tax Income | $303.00M | $1.83B |
Income Tax | $65.00M | $415.00M |
Net Income (Profit) | $239.00M | $1.41B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | WTW | MMC |
---|---|---|
Cash & Equivalents | $1.51B | $1.60B |
Total Current Assets | $15.46B | $22.46B |
Total Current Liabilities | $13.38B | $19.78B |
Long-Term Debt | $5.26B | $20.43B |
Total Shareholders Equity | $8.21B | $14.27B |
Retained Earnings | $51.00M | $25.88B |
Property, Plant & Equipment | $1.15B | $3.91B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | WTW | MMC |
---|---|---|
Operating Cash Flow | $-123.00M | $1.27B |
Capital Expenditures | $-51.00M | N/A |
Free Cash Flow | $-86.00M | $-677.00M |
Debt Repayment | $-1.00M | $-505.00M |
Common Stock Repurchase | $-200.00M | $-300.00M |
Short Interest & Institutional Ownership Analysis
Metric | WTW | MMC |
---|---|---|
Shares Short | 2.56M | 5.98M |
Short Ratio | 3.50 | 2.21 |
Short % of Float | 0.03% | 0.01% |
Average Daily Volume (10 Day) | 602,709 | 2,292,330 |
Average Daily Volume (90 Day) | 682,463 | 2,608,213 |
Shares Outstanding | 99.81M | 491.40M |
Float Shares | 97.17M | 490.71M |
% Held by Insiders | 0.00% | 0.00% |
% Held by Institutions | 0.98% | 0.93% |
Dividend Analysis & Yield Comparison: Willis Towers Watson vs Marsh & McLennan
Metric | WTW | MMC |
---|---|---|
Last 12-Month Dividend | $4.48 | $3.24 |
Last 12-Month Dividend Yield | 1.51% | 1.51% |
3-Year Avg Annual Dividend | $3.73 | $2.58 |
3-Year Avg Dividend Yield | 0.34% | 0.36% |
3-Year Total Dividends | $11.18 | $7.73 |
Ex-Dividend Date | Jun 30, 2025 | Apr 03, 2025 |